Work

Abstract P1-08-18: PIK/AKT/MTOR pathway activation in triple negative breast cancer and outcomes with matched therapy in phase I clinical trials: Response in both patients with and without direct molecular alterations

Year: 2013

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/0008-5472.sabcs13-p1-08-18

Authors: P Ganesan, S Moulder, F Janku, A Naing, S Fu, AM Tsimberidou, DD Hong, P Stephens, R Yelensky, F Meric, R Kurzrock, JJ Wheler

Institutions: The University of Texas MD Anderson Cancer Center, University of California San Diego, Moores Cancer Center, Foundation Medicine (United States)

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2014150253

Cites:

Cited by:

Related to: 10